See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2019_ACHILLION_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001070336')"} |
Graph
Absolute values for 0001070336, ACHILLION PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 275,380,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,137,000 |
| 3 | remainder_Assets | 341,000 |
| 4 | LiabilitiesCurrent | 11,829,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 17,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,896,000 |
| 9 | ResearchAndDevelopmentExpense | 50,118,000 |
| 10 | remainder_Expenses | 1,936,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,678,000 |
| 13 | remainder_ComprehensiveNetIncome | 190,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 277,858,000 |
| 1 | Liabilities | 11,846,000 |
| 2 | Expenses | 75,950,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 266,012,000 |
| 5 | NetIncome | -70,272,000 |
| 6 | ComprehensiveNetIncome | -70,177,000 |
| 7 | BaseVar | 185,761,000 |
| 8 | EconomicCapitalRatio | 2.67 |